Correction to “Combined inhibition of de novo pyrimidine synthesis and ATR promotes ATF4-mediated cell death in TP53-deficient ALL” - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Erratum for “Simultaneous Targeting of De Novo Pyrimidine Synthesis and ATR Enhances ATF4-Driven Apoptosis in TP53-Deficient Acute Lymphoblastic Leukemia”

  • October 5, 2026

Share

Objective:

To correct an error in the original article regarding the definition of ATR.

Key Findings:
  • The original article incorrectly defined ATR as 'Activating Transcription Factor 4'.
  • The correct definition of ATR is 'Ataxia Telangiectasia and Rad3-related (ATR) protein'.
Interpretation:

The article has been updated to reflect the correct terminology.

Conclusion:

The authors regret the mistake and have corrected it in the published article.

Sources:

Original Source(s)

Correction to “Combined inhibition of de novo pyrimidine synthesis and ATR promotes ATF4-mediated cell death in TP53-deficient ALL”

  • October 5, 2026

Related Content

Bridging the PSMA PET/CT access gap in prostate cancer: evidence, barriers, and priorities for implementation

A Glimpse into the Future of Analytical Instrument Design?

Michael John Fanous’s portable scanner uses AI to reconstruct images blurred by continuous high-speed acquisition

Machine Learning Alone Won’t Take Vibrational Spectroscopy Into the Clinic

Standardized preprocessing, multicenter datasets, external validation, and interpretable models may matter more than further gains in classification accuracy

  • September 30, 2026

  • 3 min